Right now a small group of investors and relativel

Right now a small group of investors and relatively few doctors know what leronlimab is capable of. The FDA will plod along until this gets widespread exposure in mainstream media. Once the public realizes what leronlimab can do they will be clamoring for the FDA to approve for whatever disease their friends and family suffer from.